Item 2. Unregistered Sales of Equity Securities
ITEM
2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.
On
May 16, 2019, the Company consummated its initial public offering of 4,600,000 Units, which includes the full exercise of the underwriter’s
over-allotment option of 600,000 Units. Each Unit consists of one ordinary share (“Ordinary Share”), one warrant (“Warrant”)
entitling its holder to purchase one-half of one Ordinary Share at a price of $11.50 per whole share, and one right to receive 1/10 of
an Ordinary Share at the closing of the Company’s initial business combination. The Units were sold at an offering price of $10.00
per Unit, generating gross proceeds of $46,000,000. Simultaneously with the closing of the initial public offering, the Company consummated
the private placement (“Private Placement”) of 225,000 units (the “Private Units”) at a price of $10.00 per Private
Unit, generating total proceeds of $2,250,000. The net proceeds from the sale of Units in the initial public offering (including the
over-allotment option units) and the Private Placement were placed in a Trust Account established for the benefit of the Company’s
public shareholders.
The
Private Units are identical to the units sold in the initial public offering. Our Sponsor, which purchased all of the Private Units,
agreed (A) to vote the private shares underlying the Private Units (the “Private Shares”) and any public shares acquired
by it in favor of any proposed business combination, (B) not to propose, or vote in favor of, an amendment to our memorandum and articles
of association that would affect the substance or timing of our obligation to redeem 100% of our public shares if we do not complete
our initial business combination within the time specified in our amended and restated memorandum and articles of association, unless
we provide our public shareholders with the opportunity to redeem their ordinary shares upon approval of any such amendment at a per-share
price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held
in the Trust Account and not previously released to us to pay our franchise and income taxes, divided by the number of then outstanding
public shares, (C) not to convert any shares (including the Private Shares) into the right to receive cash from the Trust Account in
connection with a shareholder vote to approve our proposed initial business combination (or sell any shares they hold to us in a tender
offer in connection with a proposed initial business combination) or a vote to amend the provisions of our memorandum and articles of
association relating to the substance or timing of our obligation to redeem 100% of our public shares if we do not complete our initial
business combination within the time specified in our amended and restated memorandum and articles of association and (D) that the Private
Shares shall not be entitled to be redeemed for a pro rata portion of the funds held in the Trust Account if a business combination is
not consummated. Additionally, our Sponsor agreed not to transfer, assign or sell any of the Private Units or underlying securities (except
to the same permitted transferees as the insider shares and provided the transferees agree to the same terms and restrictions as the
permitted transferees of the insider shares must agree to, each as described above) until the completion of our initial business combination.
As
of May 16, 2019, a total of $46,000,000 of the net proceeds from the initial public offering (including the over-allotment) and the Private
Placement were in a Trust Account established for the benefit of the Company’s public shareholders.
30
We
paid a total of $1,150,000 in underwriting discounts and commissions (not including the 4.0% deferred underwriting commission payable
at the consummation of initial business combination) and approximately $383,781 for other costs and expenses related to our formation
and the initial public offering.
For
a description of the use of the proceeds generated in our IPO, see Part I, Item 2 of this Form 10-Q.
On
each of May 11, 2020, August 12, 2020, and November 10, 2020, we issued an unsecured promissory note in an amount of $460,000 to the
sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete
a business combination until February 16, 2021. On each of February 5, May 11, August 11, 2021, we issued an unsecured promissory note,
in an amount of $594,467, to the sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend
the amount of available time to complete a business combination until November 16, 2021. On each of November 10, 2021 and February 7,
2022, we issued an unsecured promissory note in an amount of $546,991, to the sponsor, pursuant to which such amount had been deposited
into the Trust Account in order to extend the amount of available time to complete a business combination until May 16, 2022. On each of May 9, 2022, and August 9, 2022, we issued an unsecured promissory note in an amount of $504,431 to the sponsor, pursuant to which such amount had been deposited
into the Trust Account in order to extend the amount of available time to complete a business combination until November 16, 2022. All
these notes (the “Notes”) are non-interest bearing and are payable upon the closing of a business combination. In addition,
the Notes may be converted, at the lender’s discretion, into additional Private Units at a price of $10.00 per unit.
ITEM
3. DEFAULTS UPON SENIOR SECURITIES.
None.
ITEM
4. MINE SAFETY DISCLOSURES.
Not
applicable.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.